Literature DB >> 19200580

Mucoepidermoid carcinoma of the breast shares cytogenetic abnormality with mucoepidermoid carcinoma of the salivary gland: a case report with molecular analysis and review of the literature.

Sandra I Camelo-Piragua1, Claudine Habib, Prathima Kanumuri, Claudia E Lago, Holly S Mason, Christopher N Otis.   

Abstract

Mucoepidermoid carcinoma of the breast is a rare entity with specific morphologic and immunohistochemical features similar to its salivary gland counterpart. In the 28 reported cases to date, there has not been a comparison of the molecular characteristics of this tumor with salivary gland mucoepidermoid carcinomas. Herein, a case of mucoepidermoid carcinoma of the breast with a molecular alteration similar to its salivary gland counterpart is reported. A lymph node metastasis was identified despite a predominantly in situ component and foci of microinvasion. The morphologic, immunohistochemical, prognostic, and molecular features are discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19200580     DOI: 10.1016/j.humpath.2008.11.004

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  9 in total

Review 1.  The Spectrum of Triple-Negative Breast Disease: High- and Low-Grade Lesions.

Authors:  Felipe C Geyer; Fresia Pareja; Britta Weigelt; Emad Rakha; Ian O Ellis; Stuart J Schnitt; Jorge S Reis-Filho
Journal:  Am J Pathol       Date:  2017-07-20       Impact factor: 4.307

Review 2.  Mucoepidermoid carcinoma in a breast affected by burn scars: comprehensive literature review and case report.

Authors:  Murat Basbug; Sami Akbulut; Zulfu Arikanoglu; Nilgun Sogutcu; Ugur Firat; Mehmet Kucukoner
Journal:  Breast Care (Basel)       Date:  2011-08       Impact factor: 2.860

3.  Increased immunoexpression of trefoil factors in salivary gland tumors.

Authors:  Ponlatham Chaiyarit; Poramaporn Klanrit; Pensri Photipakdee; Ajiravudh Subarnbhesaj; Andrew S Giraud
Journal:  Clin Oral Investig       Date:  2014-05       Impact factor: 3.573

4.  Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas.

Authors:  Gregor Krings; Nancy M Joseph; Gregory R Bean; David Solomon; Courtney Onodera; Eric Talevich; Iwei Yeh; James P Grenert; Elizabeth Hosfield; Emily D Crawford; Richard C Jordan; Annemieke van Zante; Charles Zaloudek; Sandra J Shin; Yunn-Yi Chen
Journal:  Mod Pathol       Date:  2017-05-26       Impact factor: 7.842

5.  Novel therapeutic strategies for malignant salivary gland tumors: lessons learned from breast cancer.

Authors:  Ryuichi Murase; Tomoki Sumida; Akiko Ishikawa; Rumi Murase; Sean D McAllister; Hiroyuki Hamakawa; Pierre-Yves Desprez
Journal:  Int J Otolaryngol       Date:  2011-11-21

6.  Outcome analysis of 215 patients with parotid gland tumors: a retrospective cohort analysis.

Authors:  Boban M Erovic; Manish D Shah; Guillem Bruch; Meredith Johnston; U Johnston; John Kim; Brian O'Sullivan; Bayardo Perez-Ordonez; Ilan Weinreb; Eshetu G Atenafu; John R de Almeida; Patrick J Gullane; Dale Brown; Ralph W Gilbert; Jonathan C Irish; David P Goldstein
Journal:  J Otolaryngol Head Neck Surg       Date:  2015-10-29

Review 7.  Mucoepidermoid carcinoma of the breast: Four case reports and review of the literature.

Authors:  Meng Cheng; Cuizhi Geng; Tiantian Tang; Zhenchuan Song
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

8.  Enhanced activity of the CREB co-activator Crtc1 in LKB1 null lung cancer.

Authors:  T Komiya; A Coxon; Y Park; W-D Chen; M Zajac-Kaye; P Meltzer; T Karpova; F J Kaye
Journal:  Oncogene       Date:  2009-12-14       Impact factor: 9.867

9.  Risk of breast cancer in women after a salivary gland carcinoma or pleomorphic adenoma in the Netherlands.

Authors:  Matthijs H Valstar; Michael Schaapveld; Esther C van den Broek; Marie-Louise F van Velthuysen; Mischa de Ridder; Marjanka K Schmidt; Boukje A C van Dijk; Alfons J M Balm; Ludi E Smeele
Journal:  Cancer Med       Date:  2020-11-28       Impact factor: 4.452

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.